IRCT201605247411N2已完成3 期
Evaluating the Effects of Inhaled Corticosteroid on Insulin Sensitivity in Asthmatic Patient
Ahvaz Jundishapur University of Medical Science0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit(—)
- 性别
- All
入选标准
- •Inclusion criteria included: age over 15 years; stage2 or 3 asthma; FEV1 above 60%; no previous use of oral or inhaled corticosteroid and no history of diabetes.
- •Exclusion criteria included: history of diabetes or malignancy; pregnancy; acute infection; endocrine disorder; taking any medication that affects glucose metabolism; obesity (defined by BMI=30 kg/m2) and sleep apnea
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Prevention of thunderstorm asthmaAsthmaThunderstorm asthma.IRCT2016102520828N2Ahvaz Jundishapur University of Medical Sciences54
已完成
不适用
Checking of response to inhaled corticosteroid treatment on a new laboratory parameter (blood CD28) in patients of asthmaCTRI/2015/07/005977ady Hardinge Medical College80
招募中
1 期
Effect of Corton on olfactory dysfunction in COVID-19 patientsAnosmiaIRCT20200522047542N1Mashhad University of Medical Sciences70
撤回
不适用
Effectiveness of inhalated corticosteroids in preschool children following hospital admission for acute dyspnea and wheezeEpisodic viral wheezewheeze10038716NL-OMON33152Isala Klinieken62
进行中(未招募)
不适用
Effectiveness of inhaled corticosteroids in preschool children following hospital admission for acute dyspnea and wheeze - ICS@ADPDyspnea and wheeze in young children:Symptoms of dyspnea and wheeze occur frequently in young children. Most wheezing episodes in preschool children are associated with viral upper respiratory tract infections. The majority of children have become asymptomatic by the age of 6 years. About one in three preschool children with recurrent wheeze continue to wheeze after the age of six years, and these children are usually diagnosed with asthma.MedDRA version: 12.0Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-009579-36-NL
